Published in Hum Pathol on July 19, 2007
Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. PLoS One (2014) 1.42
Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment. Cancer Res (2008) 1.09
Heparan sulfate signaling in cancer. Trends Biochem Sci (2014) 0.97
Decoding the Matrix: Instructive Roles of Proteoglycan Receptors. Biochemistry (2015) 0.90
Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches. J Hepatobiliary Pancreat Sci (2014) 0.83
An immunohistochemical study of basement membrane heparan sulfate proteoglycan (perlecan) in oral epithelial dysplasia and squamous cell carcinoma. J Oral Maxillofac Pathol (2013) 0.80
Immunoscreening of the extracellular proteome of colorectal cancer cells. BMC Cancer (2010) 0.80
Heparan Sulfate Proteoglycans May Promote or Inhibit Cancer Progression by Interacting with Integrins and Affecting Cell Migration. Biomed Res Int (2015) 0.77
Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma. J Thorac Oncol (2015) 2.17
Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res (2005) 1.65
Comparison of early and 1-year follow-up results of conventional hemorrhoidectomy and hemorrhoid artery ligation: a randomized study. Int J Colorectal Dis (2003) 1.55
The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res (2004) 1.45
[Comments on "Is there any hope?" by Csaba Gaál]. Magy Seb (2010) 1.38
Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol (2002) 1.35
Fatal outcome from extreme acute gastric dilation after an eating binge. Int J Eat Disord (2006) 1.30
Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur J Cancer (2011) 1.22
Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. Hepatology (2011) 1.22
Quantitative MALDI tandem mass spectrometric imaging of cocaine from brain tissue with a deuterated internal standard. Anal Chem (2012) 1.21
Viral hepatitis: new data on hepatitis C infection. Pathol Oncol Res (2003) 1.20
Distinct claudin expression profile in histologic subtypes of lung cancer. Lung Cancer (2007) 1.14
Treatment and outcome of vaseline-induced sclerosing lipogranuloma of the penis. Urology (2008) 1.11
Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive. Hum Pathol (2008) 1.11
Effect of formalin, acetone, and RNAlater fixatives on tissue preservation and different size amplicons by real-time PCR from paraffin-embedded tissue. Diagn Mol Pathol (2004) 1.10
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol (2011) 1.09
Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma. Exp Cell Res (2012) 1.09
Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol Oncol Res (2004) 1.08
Decorin-TGFβ axis in hepatic fibrosis and cirrhosis. J Histochem Cytochem (2012) 1.08
Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol (2005) 1.06
Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Lab Invest (2010) 1.02
Acetaminophen induces ER dependent signaling in mouse liver. Arch Biochem Biophys (2006) 1.01
Evaluation of a partial genome screening of two asthma susceptibility regions using bayesian network based bayesian multilevel analysis of relevance. PLoS One (2012) 1.01
Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells. Stem Cells (2012) 1.00
Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol (2006) 1.00
Tumor-produced, active interleukin-1β regulates gene expression in carcinoma-associated fibroblasts. Exp Cell Res (2011) 0.99
Drosophila basement membrane collagen col4a1 mutations cause severe myopathy. Matrix Biol (2011) 0.98
Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells. PLoS One (2009) 0.97
Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch (2008) 0.96
Molecular characteristics of fibrolamellar hepatocellular carcinoma. Pathol Oncol Res (2012) 0.95
Changes in lipid metabolism in chronic hepatitis C. World J Gastroenterol (2005) 0.95
BGP-15 inhibits caspase-independent programmed cell death in acetaminophen-induced liver injury. Toxicol Appl Pharmacol (2009) 0.95
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma. Exp Cell Res (2012) 0.95
Different expression of occludin and ZO-1 in primary and metastatic liver tumors. Pathol Oncol Res (2008) 0.94
Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2). J Transl Med (2012) 0.93
Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers. J Histochem Cytochem (2008) 0.93
The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer. PLoS One (2013) 0.92
Genome-wide screening of genes regulated by DNA methylation in colon cancer development. PLoS One (2012) 0.92
Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas. Virchows Arch (2007) 0.92
Serum levels of angiogenic factors and their prognostic relevance in bladder cancer. Pathol Oncol Res (2008) 0.92
Endoscopic diagnosis of cytomegalovirus infection of upper gastrointestinal tract in solid organ transplant recipients: Hungarian single-center experience. Clin Transplant (2004) 0.92
Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer. J Histochem Cytochem (2010) 0.92
An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1. Pathol Oncol Res (2009) 0.91
Exhaled nitric oxide and hydrogen peroxide concentrations in asthmatic smokers. Respiration (2004) 0.91
Detection of HER-2/neu gene amplification in breast carcinomas using quantitative real-time PCR - a comparison with immunohistochemical and FISH results. Pathol Oncol Res (2006) 0.91
Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer. Cancer Sci (2011) 0.91
Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma. Lab Invest (2006) 0.91
Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration. PLoS One (2011) 0.90
Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation. Biopolymers (2011) 0.90
Identifying tissue-specific signal variation in MALDI mass spectrometric imaging by use of an internal standard. Anal Chem (2012) 0.90
Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia. Pathol Oncol Res (2005) 0.90
Claudins and tricellulin in fibrolamellar hepatocellular carcinoma. Virchows Arch (2011) 0.90
MicroRNA expression might predict prognosis of epithelial hepatoblastoma. Virchows Arch (2014) 0.90
Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions. Am J Surg Pathol (2009) 0.90
Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis. FEBS J (2013) 0.89
Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. Gynecol Oncol (2006) 0.89